Immunai
Mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
HQ location
New York City, United States
Founding location
Tel Aviv-Yafo, Israel
Website
Launch date
Employees
Enterprise value
$1.0b
Recent deals
Authorizing premium user...